Osborne Partners Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Sell
18,521
-47
-0.3% -$10.9K 0.24% 101
2025
Q4
$3.84M Sell
18,568
-827
-4% -$164K 0.2% 108
2025
Q3
$3.6M Buy
19,395
+1,741
+10% +$298K 0.18% 111
2025
Q2
$2.7M Sell
17,654
-1,513
-8% -$233K 0.14% 118
2025
Q1
$3.18M Sell
19,167
-1,432
-7% -$224K 0.18% 112
2024
Q4
$2.98M Sell
20,599
-426
-2% -$66K 0.17% 114
2024
Q3
$3.41M Buy
21,025
+16
+0.1% +$2.55K 0.19% 110
2024
Q2
$3.07M Sell
21,009
-2,055
-9% -$306K 0.18% 113
2024
Q1
$3.65M Sell
23,064
-4,021
-15% -$640K 0.22% 106
2023
Q4
$4.25M Sell
27,085
-1,178
-4% -$181K 0.28% 100
2023
Q3
$4.4M Sell
28,263
-631
-2% -$104K 0.33% 91
2023
Q2
$4.78M Sell
28,894
-375
-1% -$60.5K 0.34% 90
2023
Q1
$4.54M Buy
29,269
+313
+1% +$50.5K 0.33% 93
2022
Q4
$5.12M Sell
28,956
-313
-1% -$54K 0.4% 89
2022
Q3
$4.78M Buy
29,269
+435
+2% +$73.6K 0.4% 86
2022
Q2
$5.12M Buy
28,834
+5,622
+24% +$1M 0.39% 85
2022
Q1
$4.11M Sell
23,212
-2,761
-11% -$470K 0.3% 87
2021
Q4
$4.44M Sell
25,973
-720
-3% -$118K 0.32% 87
2021
Q3
$4.31M Buy
26,693
+53
+0.2% +$9.04K 0.35% 82
2021
Q2
$4.39M Sell
26,640
-1,561
-6% -$258K 0.36% 83
2021
Q1
$4.63M Sell
28,201
-12,158
-30% -$1.97M 0.42% 77
2020
Q4
$6.35M Buy
40,359
+670
+2% +$98.9K 0.78% 41
2020
Q3
$5.91M Sell
39,689
-1,050
-3% -$155K 1.19% 27
2020
Q2
$5.73M Sell
40,739
-667
-2% -$97.2K 1.23% 25
2020
Q1
$5.43M Sell
41,406
-650
-2% -$92.2K 1.41% 22
2019
Q4
$6.13M Sell
42,056
-7,096
-14% -$962K 1.24% 32
2019
Q3
$6.36M Sell
49,152
-155
-0.3% -$20.4K 1.28% 25
2019
Q2
$6.87M Sell
49,307
-993
-2% -$137K 1.31% 22
2019
Q1
$7.03M Sell
50,300
-11,522
-19% -$1.54M 1.37% 20
2018
Q4
$7.98M Sell
61,822
-1,511
-2% -$211K 1.19% 22
2018
Q3
$8.75M Sell
63,333
-1,031
-2% -$137K 1.12% 28
2018
Q2
$7.81M Buy
64,364
+9,543
+17% +$1.19M 1.06% 29
2018
Q1
$7.03M Sell
54,821
-699
-1% -$94.5K 0.97% 36
2017
Q4
$7.76M Sell
55,520
-1,251
-2% -$174K 1.03% 34
2017
Q3
$7.38M Buy
56,771
+960
+2% +$127K 1.01% 34
2017
Q2
$7.38M Sell
55,811
-16
-0% -$2.04K 1.05% 31
2017
Q1
$6.95M Sell
55,827
-807
-1% -$96.4K 1% 30
2016
Q4
$6.53M Sell
56,634
-1,580
-3% -$183K 0.95% 37
2016
Q3
$6.88M Sell
58,214
-450
-0.8% -$54.6K 1.03% 30
2016
Q2
$7.12M Sell
58,664
-90
-0.2% -$10.2K 1.06% 27
2016
Q1
$6.36M Sell
58,754
-1,087
-2% -$113K 0.93% 38
2015
Q4
$6.15M Sell
59,841
-43,454
-42% -$4.37M 0.89% 38
2015
Q3
$9.64M Sell
103,295
-365
-0.4% -$35.3K 1.42% 22
2015
Q2
$10.1M Sell
103,660
-4,333
-4% -$434K 1.35% 20
2015
Q1
$10.9M Sell
107,993
-18,054
-14% -$1.84M 1.43% 21
2014
Q4
$13.2M Buy
126,047
+719
+0.6% +$75.8K 1.59% 18
2014
Q3
$13.4M Sell
125,328
-382
-0.3% -$39.6K 1.73% 16
2014
Q2
$13.2M Sell
125,710
-988
-0.8% -$99.9K 1.69% 18
2014
Q1
$12.4M Sell
126,698
-760
-0.6% -$70.5K 1.63% 18
2013
Q4
$11.7M Sell
127,458
-2,806
-2% -$259K 1.52% 19
2013
Q3
$11.3M Buy
130,264
+1,907
+1% +$171K 1.58% 17
2013
Q2
$11M Buy
+128,357
New +$10.9M 1.58% 15

Other funds holding JNJ

Osborne Partners Capital Management's JNJ Position: Q1 2026 in Review

Osborne Partners Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.25% in Q1 2026, selling an estimated $10.9K and leaving 18,521 shares worth $4.53M. The position accounts for 0.24% of the portfolio, ranked #101.

Osborne Partners Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.4M in Q3 2014. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Osborne Partners Capital Management held 18,521 shares of Johnson & Johnson worth $4.53M as of Q1 2026.
  • Osborne Partners Capital Management sold 47 Johnson & Johnson shares in Q1 2026, an estimated $10.9K.
  • Johnson & Johnson made up 0.24% of Osborne Partners Capital Management's portfolio in Q1 2026, its #101 holding.
  • Osborne Partners Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Osborne Partners Capital Management's Johnson & Johnson position peaked at $13.4M in Q3 2014.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Osborne Partners Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.